Table 2.
Blood parameters in the study population before and after MPL supplementation.
| Blood parameter | Before MPL | After MPL∗ | P |
|---|---|---|---|
| Albumin (g/dL) | 4.1 (2.8–5) | 4.3 (2.6–5) | <0.001 |
| Erythrocytes (Mio/μL) | 4.2 (2.7–5.7) | 4.6 (2.8–5.7) | <0.001 |
| Haematocrit (%) | 38.7 (22.7–50.3) | 41.9 (24.7–50.3) | <0.001 |
| CRP (mg/L) | 12 (0.7–260) | 2 (0.7–305) | <0.001 |
| PSA (μg/L) | 2.3 (0–1085) | 0.4 (0–1117) | <0.001 |
| Thrombocytes (1000/μL) | 219 (27–481) | 218 (99–484) | n.s. |
| Leucocytes (1000/μL) | 7.2 (3.2–16.4) | 6.3 (2.8–24.1) | <0.001 |
| CHE (U/L) | 7419 (2185–13950) | 8221 (3959–12635) | <0.001 |
| AST (U/L) | 28.5 (9–316) | 28 (16–79) | n.s. |
| ALT (U/L) | 26 (5–170) | 26 (6–120) | n.s. |
∗Most patients underwent surgery shortly before MPL intervention.